Clinical trial
Use of TRC Autologous Bone Marrow Cells in Posterolateral Lumbar Spine Fusion
NCT00797550 is registered in ClinicalTrials.gov with Vericel Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of TRC Autologous Bone Marrow Cells in Posterolateral Lumbar Spine Fusion
- Lead sponsor
- Vericel Corporation
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- April 30, 2006
- Completion date
- October 31, 2008
- Enrollment
- 2 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
single level posterolateral spinal fusion